There continues to be pent up demand for Wegovy, but Novo Nordisk expects this to become less of a problem as more supply of the drug becomes available over the next few months, Jorgensen said
Complementary Peptide Therapies in the GLP-1 Era As GLP-1 therapies (both injectable and oral) become the pharmacological foundation of metabolic disease management, complementary peptide therapies address aspects of health that GLP-1 alone doesn't fully cover
Tirzepatide, a dual GLP-1 and GIP receptor agonist, has a longer half-life of roughly 5 days in steady-state dosing, though elimination accelerates slightly at higher doses
Wegovy serves as the primary branded semaglutide injection for weight loss, administered weekly via a pre-filled pen
It is made by Eli Lilly and can be taken as a once-daily pill at any time of day, with or without food
When you see "physician-guided," read it as "a licensed provider is part of the process," then verify the specifics that matter to you - who that provider is, what the plan costs in full, and what happens if you're not approved